Application of compound and analogue thereof as ROR gamma regulator
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- XIAMEN UNIV
- Publication Date
- 2021-08-17
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of medicine, in particular to the application of Panaxadiol and its analogs as retinoic acid receptor-related orphan receptor RORγ regulators. Background technique
[0002] The therapeutic effect of compound drugs can be exerted by binding to one or more protein "targets", thereby activating or inhibiting them to regulate the function and signal transduction of these "targets". Thus, the identification of a drug's protein target provides the basis for understanding the action of a drug's action. The elucidation of the role of these drug target proteins will provide theoretical support for the effective treatment of diseases and an effective means for the development of important new drugs.
[0003] Nuclear receptors are a group of transcription factor proteins regulated by small molecule ligands. Ligands Small molecule compounds play an important role in modulating the activity of nuclear receptors. Induc...